Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Mehr anzeigen
SEATTLE, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
clonoSEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCL Coverage leverages new Medicare episode pricing established based on updated clonoSEQ gapfill rate...
SEATTLE, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...
SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.43 | -24.4444444444 | 5.85 | 5.95 | 4.33 | 1453619 | 4.75837189 | CS |
| 4 | -0.36 | -7.53138075314 | 4.78 | 6.7 | 4.33 | 1191198 | 5.24493971 | CS |
| 12 | -0.13 | -2.85714285714 | 4.55 | 6.7 | 3.981 | 1069665 | 4.94915231 | CS |
| 26 | 0.88 | 24.8587570621 | 3.54 | 6.7 | 2.99 | 1223949 | 4.36365824 | CS |
| 52 | 0.02 | 0.454545454545 | 4.4 | 6.7 | 2.28 | 1389147 | 4.00011538 | CS |
| 156 | -22.96 | -83.8568298028 | 27.38 | 30.51 | 2.28 | 1280645 | 7.48481633 | CS |
| 260 | -24.06 | -84.4803370787 | 28.48 | 71.25 | 2.28 | 1132437 | 17.85473245 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
